Description
COMPOSITION: Each film coated extended release tablet contains Ranolazine 500 mg.
FORMULATION: TABLETS
STATUS: PRESCRIPTION ONLY DRUG
DESCRIPTION: Razocard contains sustain release Ranolazine, a second line anti anginal drug with a novel mechanism of action that offers freedom from most adverse hemodynamic effects. Razocard is indicated as add-on therapy for the symptomatic treatment of chronic angina i.e. long standing chest pain.
SIDE EFFECTS: The common side effects are dizziness, headaches, nausea, debility, and constipation.
DOSAGE/DIRECTIONS FOR USE: AS PRESCRIBED BY PHYSICIAN
Reviews
There are no reviews yet.